<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="DKK" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-3-1-285898-34356</iati-identifier>
  <reporting-org ref="XM-DAC-3-1" type="10" xml:lang="EN">
   <narrative xml:lang="EN">Ministry of Foreign Affairs, Denmark</narrative>
  </reporting-org>
  <title xml:lang="EN">
   <narrative xml:lang="EN">CEPI core contribution 2020, engagement</narrative>
  </title>
  <description type="1" xml:lang="EN">
   <narrative xml:lang="EN"></narrative>
  </description>
  <participating-org crs-channel-code="51000" role="2" type="10" xml:lang="EN">
   <narrative xml:lang="EN">Coalition for Epidemic Preparedness Innovations</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-3-1" role="1" type="10" xml:lang="EN">
   <narrative xml:lang="EN">Ministry of Foreign Affairs, Denmark</narrative>
  </participating-org>
  <other-identifier ref="Ministry of Foreign Affairs, Denmark" type="A1">
   <owner-org>
    <narrative xml:lang="EN">2020 - 11595</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier ref="Ministry of Foreign Affairs, Denmark" type="A2">
   <owner-org>
    <narrative xml:lang="EN">2020000112</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="1900-01-01" type="2"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">NA</narrative>
   </organisation>
   <person-name>
    <narrative xml:lang="EN">NA</narrative>
   </person-name>
  </contact-info>
  <recipient-region code="998" percentage="100" vocabulary="1"></recipient-region>
  <sector code="12182" percentage="100" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Medical research</narrative>
  </sector>
  <country-budget-items vocabulary="4">
   <budget-item code="954" percentage="100" vocabulary="4">
    <description>
     <narrative xml:lang="EN">FL &#xA7;06.38.02.12 Partnerships for market-based growth</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <policy-marker code="5" significance="0" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention on Biological Diversity</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention to Combat Desertification</narrative>
  </policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation</narrative>
  </policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation</narrative>
  </policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Aid to Environment</narrative>
  </policy-marker>
  <policy-marker code="1" significance="2" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Gender Equality</narrative>
  </policy-marker>
  <policy-marker code="3" significance="2" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Participatory Development/Good Governance</narrative>
  </policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Reproductive, Maternal, Newborn and Child Health (RMNCH)</narrative>
  </policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1" xml:lang="EN">
   <narrative xml:lang="EN">Trade Development</narrative>
  </policy-marker>
  <policy-marker code="10" significance="0" vocabulary="1" xml:lang="EN"></policy-marker>
  <policy-marker code="11" significance="0" vocabulary="1" xml:lang="EN"></policy-marker>
  <policy-marker code="12" significance="0" vocabulary="1" xml:lang="EN"></policy-marker>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <budget type="1">
   <period-start iso-date="2020-04-01"></period-start>
   <period-end iso-date="2020-06-30"></period-end>
   <value currency="DKK" value-date="2020-04-01">10000000</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-04-30"></transaction-date>
   <value currency="DKK" value-date="2020-04-30">10000000</value>
   <flow-type code="10"></flow-type>
   <finance-type code="110"></finance-type>
   <aid-type code="B01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-01"></transaction-date>
   <value currency="DKK" value-date="2020-05-01">10000000</value>
   <flow-type code="10"></flow-type>
   <finance-type code="110"></finance-type>
   <aid-type code="B01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <related-activity ref="XM-DAC-3-1-285898" type="1"></related-activity>
  <result type="2">
   <title>
    <narrative xml:lang="EN">Improved preparedness</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">1. Advance access to safe and effective vaccines against emerging infectious diseases.
1.1. Investigational stockpiles established. 
1.2. Plans for trials and manufacture in place.</narrative>
   </description>
   <reference code="268189" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN">Improved preparedness</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">1. Advance access to safe and effective vaccines against emerging infectious diseases.
1.1. Investigational stockpiles established. 
1.2. Plans for trials and manufacture in place.</narrative>
    </description>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">1.1.1. Vaccines candidates developed</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">1.1.1.
Through phase 2
Through phase 1
Through preclinical</narrative>
   </description>
   <reference code="268192" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN">1.1.1. Vaccines candidates developed</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">1.1.1.
Through phase 2
Through phase 1
Through preclinical</narrative>
    </description>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="2">
   <title>
    <narrative xml:lang="EN">Improved response</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">2. Accelerate the research, development and use of vaccines during outbreaks
2.1 Expected development and manufacture of vaccines for known and unknown pathogens
2.2. Facilitated field use and rapid response
2.3. Plans in place for testing and deployment during outbreaks</narrative>
   </description>
   <reference code="268194" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN">Improved response</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">2. Accelerate the research, development and use of vaccines during outbreaks
2.1 Expected development and manufacture of vaccines for known and unknown pathogens
2.2. Facilitated field use and rapid response
2.3. Plans in place for testing and deployment during outbreaks</narrative>
    </description>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="2">
   <title>
    <narrative xml:lang="EN">Improved sustainability</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">3. Sustainability
3.1. End-to-end market failures addressed
3.2. Costs reduced across the end to end spectrum of vaccine development
3.3. Successful products available to support outbreak response</narrative>
   </description>
   <reference code="268198" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN">Improved sustainability</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">3. Sustainability
3.1. End-to-end market failures addressed
3.2. Costs reduced across the end to end spectrum of vaccine development
3.3. Successful products available to support outbreak response</narrative>
    </description>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">1.2.1. Vaccine development efforts enhanced</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">NA</narrative>
   </description>
   <reference code="268193" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN">1.2.1. Vaccine development efforts enhanced</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">NA</narrative>
    </description>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">2.3.1. End to end partners engaged</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">NA</narrative>
   </description>
   <reference code="268197" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN">2.3.1. End to end partners engaged</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">NA</narrative>
    </description>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">3.1.1. Predictability of financing improved</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">NA</narrative>
   </description>
   <reference code="268199" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN">3.1.1. Predictability of financing improved</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">NA</narrative>
    </description>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">3.2.1. Efficiency improvements made</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">NA</narrative>
   </description>
   <reference code="268200" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN">3.2.1. Efficiency improvements made</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">NA</narrative>
    </description>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">3.3.1. Contingency plans developed</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">NA</narrative>
   </description>
   <reference code="268201" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN">3.3.1. Contingency plans developed</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">NA</narrative>
    </description>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">2.1.1. Pathogen specific vaccines on platforms progressing</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through phase 1
Through phase preclinincal</narrative>
   </description>
   <reference code="268195" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN">2.1.1. Pathogen specific vaccines on platforms progressing</narrative>
    </title>
    <description>
     <narrative xml:lang="EN">Through phase 1
Through phase preclinincal</narrative>
    </description>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">2.2.1. Development of technologies</narrative>
   </title>
   <description>
    <narrative xml:lang="EN"></narrative>
   </description>
   <reference code="268196" vocabulary="99"></reference>
   <indicator aggregation-status="0" ascending="0" measure="1">
    <title>
     <narrative xml:lang="EN">2.2.1. Development of technologies</narrative>
    </title>
    <description>
     <narrative xml:lang="EN"></narrative>
    </description>
    <period>
     <period-start iso-date="1900-01-01"></period-start>
     <period-end iso-date="1900-01-01"></period-end>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
